Havlir DV - Search Results

1

Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.

Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R. Lawn SD, et al. Among authors: havlir dv. AIDS. 2012 Nov 13;26(17):2121-33. doi: 10.1097/QAD.0b013e3283565dd1. AIDS. 2012. PMID: 22695302 Free PMC article. Review.

2

Opportunities and challenges for HIV care in overlapping HIV and TB epidemics.

Havlir DV, Getahun H, Sanne I, Nunn P. Havlir DV, et al. JAMA. 2008 Jul 23;300(4):423-30. doi: 10.1001/jama.300.4.423. JAMA. 2008. PMID: 18647985

3

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.

Lok JJ, Bosch RJ, Benson CA, Collier AC, Robbins GK, Shafer RW, Hughes MD; ALLRT team. Lok JJ, et al. AIDS. 2010 Jul 31;24(12):1867-76. doi: 10.1097/QAD.0b013e32833adbcf. AIDS. 2010. PMID: 20467286 Free PMC article. Clinical Trial.

4

Tuberculosis drug development: ensuring people living with HIV are not left behind.

Luetkemeyer AF, Getahun H, Chamie G, Lienhardt C, Havlir DV. Luetkemeyer AF, et al. Among authors: havlir dv. Am J Respir Crit Care Med. 2011 Nov 15;184(10):1107-13. doi: 10.1164/rccm.201106-0995PP. Epub 2011 Aug 25. Am J Respir Crit Care Med. 2011. PMID: 21868507 Free PMC article.

5

HIV and tuberculosis--science and implementation to turn the tide and reduce deaths.

Harries AD, Lawn SD, Getahun H, Zachariah R, Havlir DV. Harries AD, et al. Among authors: havlir dv. J Int AIDS Soc. 2012;15(2):17396. doi: 10.7448/ias.15.2.17396. J Int AIDS Soc. 2012. PMID: 22905358 Free PMC article. Review.

6

Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa.

Lesosky M, Raboud JM, Glass T, Brummel SS, Ciaranello AL, Currier JS, Essajee S, Havlir DV, Koss CA, Ogwu A, Shapiro RL, Abrams EJ, Myer L. Lesosky M, et al. Among authors: havlir dv. AIDS. 2020 Feb 1;34(2):311-315. doi: 10.1097/QAD.0000000000002400. AIDS. 2020. PMID: 31634186 Free PMC article.

7

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression.

Havlir DV, Gilbert PB, Bennett K, Collier AC, Hirsch MS, Tebas P, Adams EM, Wheat LJ, Goodwin D, Schnittman S, Holohan MK, Richman DD; ACTG 5025 Study Group. Havlir DV, et al. AIDS. 2001 Jul 27;15(11):1379-88. doi: 10.1097/00002030-200107270-00007. AIDS. 2001. PMID: 11504959 Clinical Trial.

8

To stop or not to stop: that is the question, but what is the answer?

Hogg RS, Havlir D, Miller V, Montaner JS. Hogg RS, et al. AIDS. 2002 Mar 29;16(5):787-9. doi: 10.1097/00002030-200203290-00015. AIDS. 2002. PMID: 11964536 No abstract available.

9

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.

Gulick RM, Meibohm A, Havlir D, Eron JJ, Mosley A, Chodakewitz JA, Isaacs R, Gonzalez C, McMahon D, Richman DD, Robertson M, Mellors JW. Gulick RM, et al. AIDS. 2003 Nov 7;17(16):2345-9. doi: 10.1097/00002030-200311070-00009. AIDS. 2003. PMID: 14571186 Clinical Trial.

10

Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.

Srikantiah P, Walusimbi MN, Kayanja HK, Mayanja-Kizza H, Mugerwa RD, Lin R, Charlebois ED, Boom WH, Whalen CC, Havlir DV. Srikantiah P, et al. Among authors: havlir dv. AIDS. 2007 Sep 12;21(14):1972-4. doi: 10.1097/QAD.0b013e32823ecf6e. AIDS. 2007. PMID: 17721107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters